Cargando…
Remdesivir – Current evidence & perspective in management of COVID-19 infection
Coronavirus infection or COVID 19 was first reported in December 2019 in Wuhan, China, and has rapidly spread to more than 200 countries. The pandemic has also taken a toll of over 2.2 million. But the elusive search for an effective antidote is still on. Pending multiple and robust randomized contr...
Autores principales: | Bajpai, Jyoti, Kant, Surya, Pradhan, Akshyaya, Verma, Ajay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208188/ https://www.ncbi.nlm.nih.gov/pubmed/34195107 http://dx.doi.org/10.4103/jfmpc.jfmpc_1754_20 |
Ejemplares similares
-
Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2022) -
Hydroxychloroquine and COVID-19 – A narrative review
por: Bajpai, Jyoti, et al.
Publicado: (2020) -
Oral tuberculosis - Current concepts
por: Sharma, Supriya, et al.
Publicado: (2019) -
Azilsartan: Current Evidence and Perspectives in Management of Hypertension
por: Pradhan, Akshyaya, et al.
Publicado: (2019) -
Curious case of primary pulmonary mucoepidermoid carcinoma
por: Bajpai, Jyoti, et al.
Publicado: (2019)